Sen. Mar Roxas on Thursday said senators remain unconvinced on ratifying the Japan-Philippines Economic Partnership Agreement (JPEPA) even as the executive branch had created an inter-agency task force to explain to senators the benefits of the bilateral economic agreement.
The Senate Trade and Commerce committee chairman said that the so-called benefits asserted by the executive branch have been countered by groups opposed to ratification of JPEPA.
Read more...
"In trade negotiations, no deal is always better than a bad deal. The challenge remains for our trade negotiators to show us—in specific, concrete terms—how this agreement will redound to the benefit of our people," said Roxas.Roxas said that even with four hearings already conducted by the Senate "the government’s presentation to the Senate is inconclusive. The ‘gives & takes’ remain unclear."
The Senate Trade and Commerce committee chairman said that the so-called benefits asserted by the executive branch have been countered by groups opposed to ratification of JPEPA.
"For example, the government asserts that JPEPA will lead to the hiring of Filipino nurses, yet the oppositors have singled-out specific chapter and verse in the agreement which says our nurses will be on OJT ("on the job training") status."Roxas maintained that he still keeps an open mind on JPEPA due to his recognition of the strong bilateral relationship between the Philippines and Japan.
"The government says that our health workers will be accorded ‘national treatment,’ or granted the same rights and privileges as Japanese nationals. However, no one could answer whether Filipino nurses will receive exactly the same benefits—monetary or otherwise—or protection as Japanese nurses," said Roxas.
Read more...
Post a Comment
Thanks a lot for visiting the Mar Roxas for President in 2010 Blog!
If you have comments, suggestions or reactions in relation with the post, please don't hesitate to write them here. Click here if you want to contact the blogger.
Suggest blog articles about Mar Roxas here. Click here!